VEGF polymorphisms and severity of atherosclerosis
Authors:
Open Access
- 3 June 2005
- journal article
- Published by BMJ in Journal of Medical Genetics
- Vol. 42 (6) , 485-490
Abstract
Introduction: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor, and neovascularisation has been shown to be important in atherosclerotic plaque development. There is some disagreement as to whether VEGF acts as a pro-atherosclerotic or anti-atherosclerotic factor. In the present study we have sought to clarify this by determining genotypes and haplotypes for three reportedly functional VEGF SNPs in a large series of well documented coronary atherosclerosis patients. Methods: VEGF −2578, −1154, and −634 single nucleotide polymorphisms were genotyped in 984 subjects from the Southampton Atherosclerosis Study, using the 5′ nuclease assay for allelic discrimination (TaqMan). Results: VEGF −2578 genotypes showed a significantly different distribution in patients without myocardial infarction when stratified according to number of diseased arteries. VEGF −2578 was also associated with mean number of stenotic segments in the same patient group. The AA genotype was a risk factor and CC was protective. These associations were significant before and after adjustment for classic risk factors, and were reflected in associations between VEGF haplotypes and the number of diseased arteries and stenotic segments. As VEGF −2578 CC has been provisionally shown to be associated with higher VEGF expression than the AA genotype, these results are consistent with a protective effect for VEGF in atherosclerosis development. Some changes in VEGF −1154 genotype frequencies were also detected, but no significant associations were detected for any one particular genotype. Conclusions: This study provides preliminary evidence that VEGF polymorphism is associated with development of atherosclerosis, possibly via regulation of VEGF expression, supporting a protective effect for VEGF in atherosclerosis. These results require replication in an independent study group, combined with study of additional candidate polymorphisms in the VEGF gene.Keywords
This publication has 28 references indexed in Scilit:
- Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide SynthesisCirculation, 2002
- Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Acute Renal Allograft RejectionJournal of the American Society of Nephrology, 2002
- Vascular endothelial growth factor enhances atherosclerotic plaque progressionNature Medicine, 2001
- A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma LevelsJournal of Vascular Research, 2000
- IDENTIFICATION OF POLYMORPHISMS WITHIN THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENE: CORRELATION WITH VARIATION IN VEGF PROTEIN PRODUCTIONCytokine, 2000
- Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor geneHuman Immunology, 1999
- Vascular Endothelial Growth Factor-Induced Migration of Vascular Smooth Muscle Cells in VitroMicrovascular Research, 1999
- Reciprocal relation between VEGF and NO in the regulation of endothelial integrityNature Medicine, 1997
- Passivation of Metallic Stents After Arterial Gene Transfer of phVEGF165Inhibits Thrombus Formation and Intimal ThickeningJACC, 1997
- Stent EndothelializationCirculation, 1997